New Delhi: Serum Institute of India CEO Adar Poonawalla on Wednesday said the company has restarted manufacturing of COVID-19 vaccine Covishield amid rising numbers of...

The Serum Institute’s made-in-India vaccine against cervical cancer, CERVAVAC, will be available in the market this month at an MRP of INR 2,000 per vial...

New Delhi, Jan. 18 (PTI): Serum Institute of India has written to the Union Health Ministry seeking the inclusion of its Covid vaccine Covovax in...

New Delhi, June 4 (PTI): The DCGI has granted permission to the Serum Institute of India (SII) to manufacture the Sputnik Covid-19 vaccine in India...

New Delhi, May 30 (PTI): Serum Institute of India (SII) has informed the government that it will be able to manufacture and supply nine to...

New Delhi, Mar. 1 (IANS): Chinese and Russian-linked hacking campaigns in recent weeks targeted Indian vaccine makers Serum Institute of India (SII) and Bharat Biotech, cyber...

Pune, Jan. 21 (IANS): At least five persons suffocated to death in a major fire that engulfed an under-construction building in a plant of global...

New Delhi, Sep. 16 (PTI): Drugs Controller General of India (DCGI) Dr V G Somani has gave permission to Serum Institute of India to resume...

New Delhi, Sep. 10 (IANS):The Serum Institute of India (SII), which was conducting the India trials for the coronavirus vaccine being developed by Oxford University,...

New Delhi, Sep. 9 (IANS): The clinical trials of Oxford vaccine will continue in India as usual as it has faced no issue at all,...